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ABSTRACT
Introduction: For the last 30 years, tobacco smoking has
continued to be the leading cause of premature deaths in
Malaysia. Majority of the smokers in Malaysia are at the pre-
contemplation and contemplation stages. Therefore, for the
purpose of increasing smoking cessation among this group,
the strategies that motivate them to quit smoking have to be
reviewed.
Objective: This study aims to evaluate the effectiveness of
carbon monoxide measurement feedback and the standard
brief motivation adopted to encourage the smoker to quit.
Methods: A single-blind, cluster randomised controlled trial
was conducted at ten tertiary colleges in Selangor. The
study recruited young adult smokers at the pre-
contemplation and contemplation stages. The subjects in
the control group received a standard brief motivational
strategy. On the other hand, the intervention group received
additional carbon monoxide measurement and a
motivational feedback module. A follow up was conducted at
the first, third and sixth month to measure changes in
smoking cessation stage. Subsequently, the secondary
outcomes of a mean number of cigarette consumption and
quit smoking attempt were analysed. A total of 160 subjects
were required to detect the expected difference of 17% in
primary outcomes between the groups. This study utilised
Generalised Estimating Equations (GEE) to handle the
clustering effects.
Conclusion: Biomedical risk assessment feedback
mechanism by using carbon monoxide is a promising aid to
motivate the smoker to quit. This mechanism is a relatively
easy, quick and non-invasive technique. Thus, it can be
utilised as a reinforcement relating to the harmful effect of
smoking. Besides, it can also increase the smokers’ self-
efficacy and decisional balance to adopt behavioural
changes.
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INTRODUCTION
For the last 30 years, tobacco smoking has continued to be
the leading cause of premature deaths in Malaysia. The
continuance of the current trend and pattern of smoking in
Malaysia will impose a significant burden on future
healthcare. Based on the latest National Health and
Morbidity Survey 2015,1 the prevalence of tobacco smoking in
Malaysia was 22.8%. Nevertheless, in terms of age group, the
prevalence of smoking is significantly lower among young
adults i.e., 13.2% of the group aged 18 to 19 and 25.3% of the
group aged 20 to 24. The trend among this age group was
similar to result showed in the previous Global Adult Tobacco
Survey 2011.2 In fact, compared to other age groups, the
current smokers in this age group had the highest prevalence
of making a quit attempt in the past 12 months (55.7%) and
being advised to quit smoking by a healthcare provider in the
past 12 months (90.2%). Therefore, there is plenty of
opportunities to reduce the prevalence of smoking by
focusing on a cohort of this age group of young adults.
Malaysia, as one of the ratifying parties in the Framework
Convention on Tobacco Control (FCTC), has pledged to
promote smoking cessation. The current management of
smoking cessation in Malaysia includes delivering of a
standard brief motivation at healthcare facilities3 to motivate
the smokers who have no attempt to quit.
Transtheoretical Model (TTM) has been widely used to
describe smoking behaviour based on the behavioural theory
by Prochaska.4 There are five stages of change: namely (i)
pre-contemplation, (ii) contemplation, (iii) preparation, (iv)
action, and (v) maintenance. At the pre-contemplation stage,
the smokers have no intention to change behaviour in the
next six months. During the contemplation stage, they
develop an intention. Subsequently, at the preparation stage,
the smokers intend to change in the next few months. The
smokers usually go to the quit smoking clinic in the last three
stages. During the fourth stage, they have made specific
changes within the last six months through maintenance.
While attention has been provided regarding smoking
cessation, the stage-based strategy is important to mobilise
the smokers from the lower stages.5 Based on the TTM Model
for smoking cessation stages of change, 70% of the smokers
in Malaysia were at the contemplation stage whereas 30% at
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the pre-contemplation stage.5 Another study showed that
among the younger smokers, 87.36% of them were at pre-
contemplation and contemplation stages whereas only
12.62% of them were at the preparation stage.6 A local study
conducted in Johor discovered that almost 60% of the current
young smokers had the intention to quit.7
TTM is also widely used for smoking intervention. Specific
intervention to the lower stage of pre-contemplation and
contemplation groups can increase uptake at quit smoking
clinic as it is predictive of making a quit attempt and
smoking relapse.8 Thus, stage-based intervention by using
TTM on the young adults has a promising result. A
systematic review of smoking cessation intervention among
the young adults discovered three studies, targeting at the
stages of change of individual participants by using TTM.9
The result of these studies indicated the intervention of brief
clinical message, motivational counselling and booster
sessions by utilising TTM-based computer expert system had
a risk ratio of 1.56 (95%CI 1.21 - 2.01) for cessation outcome
at 1 year compared to standard care.9 Further review on
stage-based tobacco intervention discovered a significant
difference in the progress of the stages, intention to quit and
smoking cessation outcome. A randomised clinical trial in
Turkey by using TTM-based counselling discovered that the
rates of smoking cessation and progress are significant
compared to control.10
Furthermore, apart from the five stages of change, the model
indicated ten processes of change which explained how
cognition, emotion and behaviour changes take place. The
intervention should apply the specific process of change, such
as consciousness-raising at the early stage.11 The conscious
awareness also requires internal cues and external cues. The
intervention on external cues, such as pictorial warning on
cigarette packages, has proved to be successful.12 On the other
hand, the intervention on internal cues, such as depression
and anxiety, also has shown to be effective. Nevertheless,
these two cues act independently and not synergistically.13
Moreover, utilising carbon monoxide feedback forms of the
biomedical risk assessment feedback to motivate the smokers
in quitting. Biomedical risk assessment, includes spirometer,
atherosclerotic plaque imaging, genetic testing or carbon
monoxide analyser, uses the external cues to demonstrate the
effect and severity of smoking to the smokers.
Nevertheless, it is relatively easy, quick and less technicality
to use carbon monoxide analyser. One of the first trials by
Jamrozik et al. in 1984 was conducted in general practice in
London and Oxford.14 The four-arm trial comprised of control
with brief advice, exhaled carbon monoxide feedback and
health visitor showed no significant difference in attempts to
stop smoking but the significant difference on quit smoking.
The exhaled carbon monoxide group had a significant 13.9%
of quit rate compared to 8.5% of the control group adjusted
for a social group class. It indicated that the added impact of
carbon monoxide measurement.14 Several other studies
showed the promising results in increasing the level of
motivation to quit.15,16 A study conducted by Choi et al. in
Korea compared the CO measurement feedback with self-
help material. The study discovered a significant increase in
motivation after four weeks but with wide confidence
intervals due to small sample size.15 In 2011, a randomised
clinical trial conducted in the UK discovered that adding
carbon monoxide measurement to standard quit advice
significantly increased the motivation to quit. Nevertheless, it
did not significantly differ in quit attempts or abstinence16
Thus, it can be concluded that carbon monoxide
measurement feedback immediately increases the cognitive
effect. Nonetheless, the effect does not last long transforming
into a quit attempt or abstinence. It raises the threat
appraisal that can be exploited among the unmotivated
smokers. Nevertheless, the strategies to provide the smokers
with biofeedback has not been explored in Malaysia. Carbon
monoxide analyser (CO analyser) is usually used to confirm
smoking status at the last three stages instead of being used
as a biofeedback mechanism at the initial stage to develop a
smoker’s intention to quit. The measurement of carbon
monoxide is a relatively non-invasive and easy technique.
Thus, it can be employed easily. This study aims to explore its
effect on the smoker’s motivation to quit compared to the
current standard brief motivational strategy. Furthermore,
the purpose of the study is to research the effectiveness of CO
analyser as biofeedback compared to the standard brief
motivation on the lower scale of stages by measuring: (i)
motivational stage as the primary outcomes; and (ii)
behaviour (mean number of cigarettes smoked per day) and
number of quit attempts as the secondary outcomes.
MATERIALS AND METHODS
Design and settings
A single-blind, cluster randomised controlled trial was
conducted in all community colleges in Selangor. There are
10-community colleges in Selangor and they were
randomised to be either a control group or intervention
group. The healthcare professionals provided a standard brief
motivational intervention to the subjects in the control
group, whereas the intervention group received an additional
carbon-monoxide measurement feedback. Figure 1 shows the
CONSORT diagram for the study.
Study population
The study population consisted of college students who are
smokers, aged from 18 to 24 years old. Inclusion criteria were
smokers at the pre-contemplation and contemplation stages.
The “smoker” is defined based on the Centers for Disease
Control and Prevention (CDC) criteria as “someone who has
smoked at least 100 cigarettes in their lifetime, including
every day and someday smokers”.17 Those who currently on
any smoking cessation programme or self-quit attempt were
excluded as they were already at the action and maintenance
stages. Those who have any lung or heart diseases as being
declared in their entrance health examination form were also
excluded. The college entrance health examination included
chest radiograph examination and medical check-up by
medical practitioner.
Subjects recruitments
The first phase of recruitment was the screening for eligible
smokers at all campuses. Such screening was conducted
through a preliminary questionnaire. A single stage
sampling was only conducted within college level. Further, a
simple random sampling was conducted to get the required
participants in each college after getting their informed
consent. The second phase of recruitment involved random
allocations of each college to either intervention or control
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Fig. 1: CONSORT Diagram
group by using the restricted block randomisation. The
colleges received either control or intervention arm, i.e., five
colleges in each arm. During the baseline and the follow-up
period, those who intended to quit were referred to the nearest
quit smoking clinics in government health facilities. This is to
ensure they received appropriate treatment.
Sample size
Under individual randomisation, the sample size was
calculated based on Lwanga and Lemeshow formula,18 with
an alpha level of 0.05 and power of 0.8, and an estimated
attrition rate of 10%. Thus, 67 subjects were required in each
group to detect a difference equal to or more than 14% in
smoking cessation phase. On the other hand, the cluster
sample size was based on the formula for the fixed number of
cluster.19 Based on Suen et al., 2016, with the intra-cluster
correlation (ICC) of 0.005, a total of 16 subjects per cluster
was required to detect such differences.20
Intervention
The control group received a standard brief motivational
strategy based on the national Clinical Practise Guidelines
(CPG) that was provided to the smokers attending
government healthcare facilities. The brief motivation
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consists of relevance, risks, rewards, roadblocks and
repetition themes. The purpose of the brief motivation is to
support the patient’s self-efficacy. The counsellors at both
colleges were provided with a standard training of delivering
the brief motivation. On the other hand, in addition to the 5R
brief motivation, the intervention group received a
biofeedback module by using a CO analyser. The CO level
was measured by using ICO Smokelyzer (Bedfont Scientific
Ltd., Rochester, UK) where the CO analyser test was
connected to the readily available mobile phone application.
The measurement was repeated twice with one week apart to
reflect the changes in CO level. A brief explanation regarding
the test was explained to the subjects. Subsequently, the
application displayed the result to the subjects with an
interpretation of the results. After that, a feedback consisted
of 20 minutes of slideshow incorporating four themes, i.e. the
harmful effect of tobacco smoking, the effect of CO, the
measurement of CO and benefit of smoking cessation. The
contents of the result and the slideshow were emailed to the
subjects for reinforcement. The purpose of the CO test is to
enhance self-efficacy and the awareness of the smokers
regarding the risk of smoking. The counsellor at the college
would spend 20 minutes for each session to complete the brief
motivational strategy. For the intervention group, each
session of brief motivational strategy and biofeedback
module would take one hour.
Outcome assessment
The outcome assessment was conducted on the first, third
and sixth-month post-intervention via questionnaire. The
primary outcome was the proportion of changes relating to
the stages of smoking cessation based on the TTM in the third
and sixth-month. The outcome was recorded as either
increase in stages (0), or maintain or decrease in stages (1).
The secondary outcome of the study referred to the behaviour
changes regarding a mean number of cigarettes smoked per
day and quit attempt at first, third and sixth month. The
outcome measurement was conducted as a follow-up by the
counsellors at first, third and sixth month to conduct the
assessment of the smoking cessation stages.
Variable measurement
At a starting position, a questionnaire was used to collect the
following information: (a) sociodemographic characteristics;
(b) smoking characteristics; (c) Fagerstrom Test for Nicotine
Dependence (FTND); (d) peer pressure inventory; and (e)
environmental tobacco smoke (ETS) exposure. The
sociodemographic characteristics of the subjects include age,
gender, ethnicity, religion and family per capita income.
Besides, the smoking characteristics include a mean number
of cigarette smoker per day, the age of smoking initiation, a
method of acquiring first cigarette, type of smoking, previous
quit attempts, and average money spent for smoking per
month. On the other hand, the physical dependence on
nicotine was measured by utilising a modified version of the
FTND that has been translated and validated in the local
language. The Peer Pressure Inventory was used to assess the
direction and intensity of peer pressure from three domains
only i.e. peer conformity, peer involvement and misconduct.21
The ETS questionnaire was employed to measure the
exposure at the institution, home and social settings which
was categorised into high or low exposure. In the third and
sixth month, the outcome was measured by employing a
similar questionnaire to assess the stage of smoking
cessation, date of smoking cessation, and mean number of
cigarette smoke per day.
Data analysis
Data was entered and analysed in R Studio version 1.0.153 by
using Generalised Estimating Equations (GEE) package. In
descriptive statistics, the categorical data results were
described as a percentage (%) while continuous data as either
mean and standard deviation or median and interquartile
range. Multiple imputations were also used for the missing
data and sensitivity analysis was conducted. Significant level
was taken at alpha (α) of 0.05, whereas all P values reported
for two-sided. Baseline comparison was analysed by using
chi-square test and independent t-test. The outcome variables
were compared at the beginning and the effects of the
intervention after the first, third and sixth month using GEE.
The young adult smoking intervention study usually
considers the nesting of intact social groups within each
group. Therefore, analysis of the intervention effect has to be
analysed at the cluster level and taking into account the
intra-class correlation among observation within each
cluster. This study adopted a binary GEE model to test the
difference between groups after adjusting for potential
confounder and multiple imputations for those failed to
follow-up. Subgroups analyses were conducted to measure
the interaction between time factors x group interaction. To
correct for multiple testing, Bonferroni correction will be used
to adjust probability values. This study carried out an
intention to treat analysis (ITT). Plots were produced to
describe the time relationship between outcome and
interaction with the group.
RESULTS
The proportion of changes in stage of change was expected to
be higher in the intervention group compared to the control
group. Apart from that, it was expected to sustain in the first,
third and sixth month. Such proportion of changes was to be
translated into a mean number of cigarette smoked per day
and number of a quit attempt.
DISCUSSION
Smoking is one of the leading modifiable risk factors for non-
communicable worldwide disease. As shown by the survival
curve, the majority of the smoker relapse at the initial
attempt and subsequently manage to quit successfully after
several attempts. Therefore, the interventions to mobilize the
smokers in making initial quit attempt is equally important.
Despite brief advice has proved to be cost effective,22 adding
the biomedical risk assessment may increase the overall
results. The figures indicated that improvement can be still
made by the current management that promotes smoking
cessation. There are a group of smokers who never quit. It is
unlikely for the young adults to undertake pharmacotherapy
or behavioural treatments.23 Nevertheless, the young adults
have the highest prevalence of smokers whom the healthcare
workers had advised to quit smoking. Thus, the intervention
aims to resolve this issue, particularly among the young
smoker cohort. This group of smokers requires an
intervention that provides external cues to raise their
awareness of smoking cessation intention. The progression in
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the stage of change requires some changes in perception of
smoking.24 The pictorial warning on cigarette packs affect the
smoking frequency of the young smokers and forms the
incremental effects on their quitting thought.25 Similarly, the
information provided by the CO analyser is able to convey
the negative health belief about smoking to the smokers and
thus changes the smokers’ decisional balance. Ultimately, the
smokers will make the intention to quit.
Nevertheless, there are some limitations to this study. The
emailed CO result and interpretation were assumed to be
received by the smokers and thus reinforced the risk of
smoking on them. Another potential limitation of the study
is regarding the privacy and confidentiality of the health
informatics. There is a rising concern on the privacy of
sensitive health-related data, particularly with health mobile
apps.26 Nevertheless, it is beyond the resources of this study to
develop security and privacy protection in addition to what
has been supplied by the device provider.
The results of this study can provide an insight on whether
biomedical risk assessment can be utilised as an additional
motivational tool for the young smokers to quit smoking. It is
expected that the CO measurement can be used to increase
smokers’ motivation to change their behaviour and quit
smoking.
CONCLUSION
Carbon monoxide measurement is a relatively simple, quick
and non-invasive method which can be adopted as an
additional method to motivate the smokers in quitting.
Nevertheless, the future study should expand into other
subgroup populations of smokers and other issues such as
cost-effectiveness study.
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